OCTAPLASLG

This brand name is authorized in Ecuador, Estonia, Finland, France, Croatia, Malta, Poland, Romania, United Kingdom

Active ingredients

The drug OCTAPLASLG contains one active pharmaceutical ingredient (API):

1 UNII 6D53G0FD0Z - PLASMA PROTEIN FRACTION (HUMAN)

Read about

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
OCTAPLASLG Solution for infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B05AA	Blood substitutes and plasma protein fractions	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products
Discover more medicines within B05AA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 223-MBE-1221
Country: EE	Ravimiamet	Identifier(s): 1593187, 1674592, 1674604, 1685235, 1802652, 1802663, 1802674, 1802685
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 004263, 004280, 004295, 004297
Country: FR	Base de données publique des médicaments	Identifier(s): 60074795
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 336602, 336605, 336610, 336613
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-098600779, HR-H-223252057
Country: MT	Medicines Authority	Identifier(s): MA1219/00901, MA1219/00902
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100340046
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65357001, W65357002, W65357003, W65357004